Blog

Dr. Ghosh on Frontline Immunotherapy in Hodgkin Lymphoma – OncLive


OncLive

Dr. Ghosh on Frontline Immunotherapy in Hodgkin Lymphoma
OncLive
Ghosh says that there may be a role for immunotherapy in the frontline setting. There are trials of immunotherapy currently ongoing, but there is not yet a head-to-head comparison. Trials are being planned to move PD-1 inhibitors to the frontline

2018-05-16 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.